TY - JOUR
T1 - Antimicrobial activity and cell selectivity of synthetic and biosynthetic cationic polymers
AU - Venkatesh, Mayandi
AU - Barathi, Veluchamy Amutha
AU - Goh, Eunice Tze Leng
AU - Anggara, Raditya
AU - Fazil, Mobashar Hussain Urf Turabe
AU - Ng, Alice Jie Ying
AU - Harini, Sriram
AU - Aung, Thet Tun
AU - Fox, Stephen John
AU - Liu, Shouping
AU - Yang, Liang
AU - Barkham, Timothy Mark Sebastian
AU - Loh, Xian Jun
AU - Verma, Navin Kumar
AU - Beuerman, Roger W.
AU - Lakshminarayanan, Rajamani
N1 - Publisher Copyright:
© 2017 Venkatesh et al.
PY - 2017
Y1 - 2017
N2 - The mammalian and microbial cell selectivity of synthetic and biosynthetic cationic polymers has been investigated. Among the polymers with peptide backbones, polymers containing amino side chains display greater antimicrobial activity than those with guanidine side chains, whereas ethylenimines display superior activity over allylamines. The biosynthetic polymer ε-polylysine (εPL) is noncytotoxic to primary human dermal fibroblasts at concentrations of up to 2,000 μg/ml, suggesting that the presence of an isopeptide backbone has greater cell selectivity than the presence of α-peptide backbones. Both εPL and linear polyethylenimine (LPEI) exhibit bactericidal properties by depolarizing the cytoplasmic membrane and disrupt preformed biofilms. εPL displays broad-spectrum antimicrobial properties against antibiotic-resistant Gram-negative and Gram-positive strains and fungi. εPL elicits rapid bactericidal activity against both Gram-negative and Gram-positive bacteria, and its biocompatibility index is superior to those of cationic antiseptic agents and LPEI. εPL does not interfere with the wound closure of injured rabbit corneas. In a rabbit model of bacterial keratitis, the topical application of εPL (0.3%, wt/vol) decreases the bacterial burden and severity of infections caused by Pseudomonas aeruginosa and Staphylococcus aureus strains. In vivo imaging studies confirm that εPL-treated corneas appeared transparent and nonedematous compared to untreated infected corneas. Taken together, our results highlight the potential of εPL in resolving topical microbial infections.
AB - The mammalian and microbial cell selectivity of synthetic and biosynthetic cationic polymers has been investigated. Among the polymers with peptide backbones, polymers containing amino side chains display greater antimicrobial activity than those with guanidine side chains, whereas ethylenimines display superior activity over allylamines. The biosynthetic polymer ε-polylysine (εPL) is noncytotoxic to primary human dermal fibroblasts at concentrations of up to 2,000 μg/ml, suggesting that the presence of an isopeptide backbone has greater cell selectivity than the presence of α-peptide backbones. Both εPL and linear polyethylenimine (LPEI) exhibit bactericidal properties by depolarizing the cytoplasmic membrane and disrupt preformed biofilms. εPL displays broad-spectrum antimicrobial properties against antibiotic-resistant Gram-negative and Gram-positive strains and fungi. εPL elicits rapid bactericidal activity against both Gram-negative and Gram-positive bacteria, and its biocompatibility index is superior to those of cationic antiseptic agents and LPEI. εPL does not interfere with the wound closure of injured rabbit corneas. In a rabbit model of bacterial keratitis, the topical application of εPL (0.3%, wt/vol) decreases the bacterial burden and severity of infections caused by Pseudomonas aeruginosa and Staphylococcus aureus strains. In vivo imaging studies confirm that εPL-treated corneas appeared transparent and nonedematous compared to untreated infected corneas. Taken together, our results highlight the potential of εPL in resolving topical microbial infections.
KW - Antimicrobial activity
KW - Cationic polymers
KW - Cell selectivity
KW - Membrane selectivity
KW - Rapid bactericidal activity
KW - Superior biocompatibility index
KW - Topical bacterial infections
UR - http://www.scopus.com/inward/record.url?scp=85029759720&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85029759720&partnerID=8YFLogxK
U2 - 10.1128/AAC.00469-17
DO - 10.1128/AAC.00469-17
M3 - Article
C2 - 28784676
AN - SCOPUS:85029759720
SN - 0066-4804
VL - 61
JO - Antimicrobial Agents and Chemotherapy
JF - Antimicrobial Agents and Chemotherapy
IS - 10
ER -